TCL Archive In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas February 3, 1984
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive CCOPs At Six Months: Sme Exceeding Patient Goals, Most Are Meeting Schedules March 30, 1984
TCL Archive DRCCA Board Okays Concepts Of New Cooperative Agreements For Smoking Program, Flow Cytometry For Bladder Cancer October 28, 1983
